Medpace Logo

For Immediate Release: January 18, 2019

Julie Hopkins
513-579-9911 x 12627

Medpace’s Flagship Site Programme for High-Achieving Sites
Exemplifies Commitment to Accelerating Clinical Research

Royal Free London NHS Foundation Trust Receives Flagship Site Status

CINCINNATI, OH  – (January 18, 2019) – Medpace (MEDP) a scientifically-driven, global full-service clinical research organization (CRO), announced that Royal Free London NHS Foundation Trust has achieved the status of a Flagship Site—the highest level of site certification in Medpace’s site relationship programme.  Royal Free London’s outstanding success with respect to study recruitment and data quality drove the designation.

Medpace’s Flagship Site Programme was created to build and strengthen public health sector and investigator site ties, to accelerate clinical development, and to strengthen project deliverables. Only the highest-achieving sites who consistently demonstrate excellence in areas such as start up, recruitment, retention, and data quality are certified.

The partnership endorses Royal Free Hospitals to be more accessible to cutting-edge trials being run by Medpace. Medpace and Royal Free London will work towards:

  • Increasing patient accessibility to take part in research for potential new therapeutics
  • Engaging investigators/patients at protocol development stage
  • Sharing Medpace’s portfolio of clinical trials to enhance study delivery
  • Alignment of process to ensure efficiency with study start-up and execution

“Medpace is pleased to certify Royal Free London as a Flagship site, in recognition of its high-level of excellence and involvement in clinical research,” commented Andrew Masih, Medpace Executive Director. “Royal Free London have shown outstanding contributions to clinical research with dedicated team who are driven to produce quality results. Together, we will strive towards executing innovative trials at the highest levels to accelerate the development of safe and effective medical therapeutics.”

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,800 people across 36 countries.

About Royal Free

The Royal Free London NHS Foundation Trust believes clinical research is key to delivering excellent patient care. We are proud to be a research active trust and value our excellent investigators, outstanding research workforce and research patients.  The Royal Free London recruits more than 12,000 patients annually to research projects, which are ethically approved by the Health Research Authority’s registered Research Ethics Committee, and conducted in accordance with international regulatory standards.